Showing 1 - 1 results of 1 for search 'Sicen Pan', query time: 0.02s Refine Results
  1. 1
    Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system

    Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system by Rui Xiong, Jing Lei, Sicen Pan, Hong Zhang, Yongtao Tong, Wei Wu, Yi Huang, Xiaodan Lai

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: